COMMUNIQUÉS West-GlobeNewswire

XORTX Announces Issuance of Stock Options
21/03/2018
CALGARY, Alberta, March 20, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney [...]
scPharmaceuticals Inc. Reports Fourth Quarter 2017 Financial Results
21/03/2018
Announced $147.7 Million of equity capital raising in 2017; Completed an Initial Public Offering; Advances towards FUROSCIX™ PDUFA date BURLINGTON, Mass., March 20, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. ( [...]
DiaMedica Therapeutics Announces Closing of Private Placement
20/03/2018
MINNEAPOLIS, March 20, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “ Company ”) (TSX-V: DMA ) (OTCQB:DMCAF) is pleased to announce the successful completion of the first closing of a private placement for [...]
Immunovaccine Announces Year-End 2017 Financial Results
20/03/2018
HALIFAX, Nova Scotia, March 20, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology corporation, today released its financial and operational results for the fiscal [...]
DBV Technologies Annonce le lancement d'une offre globale d'actions ordinaires, pouvant prendre la forme d'American Depositary Shares
20/03/2018
Montrouge, France, le 20 mars 2018, 21h00 CET DBV Technologies Annonce le lancement d'une offre globale d'actions ordinaires, pouvant prendre la forme d'American Depositary Shares DBV Technologies (la « Société ») ( [...]
Galapagos increases share capital through warrant exercises
20/03/2018
Mechelen, Belgium; 20 March 2018, 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 298,184 new ordinary [...]
R1 RCM to Begin Trading on the Nasdaq Global Market
20/03/2018
CHICAGO, March 20, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (“R1” or the “Company”) (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced it has [...]
Orion Biotechnology Canada Announces Closing of $5 Million Financing
20/03/2018
OTTAWA, March 20, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd today announced it has completed a US$5 million private placement financing late last year. “We are delighted to have secured the financial [...]
Emblem Corp. Issues President’s Letter to Shareholders
20/03/2018
TORONTO, March 20, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) (" Emblem " or the " Corporation ") provides a Letter to its Shareholders as follows: Spring is upon us, and Emblem is ready to bloom. Having [...]
Strongbridge Biopharma Announces Issuance of Patent for RECORLEV™ (levoketoconazole) for the Treatment of Cushing’s Syndrome
20/03/2018
DUBLIN, Ireland and TREVOSE, Pa., March 20, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP ), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
Prothena Announces Global Neuroscience Research & Development Collaboration with Celgene for Novel Therapies for Patients with Neurodegenerative Diseases
20/03/2018
Prothena to receive a $100 million upfront payment and a $50 million equity investment by Celgene, with potential license payments and regulatory and commercial milestones, plus additional royalties on net sales from [...]
Alder BioPharmaceuticals® Appoints Paul B. Cleveland as Interim President and Chief Executive Officer
20/03/2018
BOTHELL, Wash., March 20, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares
20/03/2018
Montrouge, France, March 20, 2018, 9:00 p.m., CET DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares DBV Technologies (the " [...]
Tetraphase Pharmaceuticals to Present at 17th Annual Needham Healthcare Conference
20/03/2018
WATERTOWN, Mass., March 20, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc . (NASDAQ: TTPH ) a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug- [...]
Altimmune to Announce Year End 2017 Financial Results on March 29
20/03/2018
GAITHERSBURG, Md., March 20, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage immunotherapeutics company, today announced that it will announce financial results for the quarter and year ended [...]
Trevena to Present at the Needham & Company 17th Annual Healthcare Conference
20/03/2018
CHESTERBROOK, Pa., March 20, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced that it will be presenting at the Needham & Company 17th Annual Healthcare Conference on Tuesday, March 27, 2018, [...]
Selecta Biosciences to Present at the Needham Healthcare Conference on March 27, 2018
20/03/2018
WATERTOWN, Mass., March 20, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB ), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by avoiding [...]
BIOPHYTIS files for Orphan Drug Designation for Sarconeos in Duchenne Muscular Dystrophy (DMD)
20/03/2018
Presentation of MYODA: a new clinical program in the treatment of Duchenne Muscular Dystrophy PARIS, March 20, 2018 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris:ALBPS), a biotechnology company specializing in [...]
CROSSJECT :Résultats annuels & point d'activité
20/03/2018
Résultats annuels et point d'activité Une étape importante en 2017 : mise en route de l'outil industriel Résultat courant avant impôts 2017 stabilisé à - 8,5 M€ Trésorerie à fin 2017 : 2,8 M€ ; 8 M€ d'apports [...]

Pages